Robert Iwaoka

Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data

Philippe Gabríel Steg, Deepak L. Bhatt, Christian W. Hamm et al. · The Lancet · 2013 · 341 citations

Medicine, Cardiology, Surgery +15

Rheolytic Thrombectomy With Percutaneous Coronary Intervention for Infarct Size Reduction in Acute Myocardial Infarction

Arshad Ali, David A. Cox, Nabil Dib et al. · Journal of the American College of Cardiology · 2006 · 286 citations

Medicine, Cardiology, Surgery +16

Comparative Early and Late Outcomes After Primary Percutaneous Coronary Intervention in ST-Segment Elevation and Non–ST-Segment Elevation Acute Myocardial Infarction (from the CADILLAC Trial)

David A. Cox, Gregg W. Stone, Cindy L. Grines et al. · The American Journal of Cardiology · 2006 · 71 citations

Medicine, Cardiology, Surgery +16

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

Muthiah Vaduganathan, Robert A. Harrington, Gregg W. Stone et al. · Journal of the American College of Cardiology · 2017 · 57 citations

Medicine, Cardiology, Pharmacology +14

Outcomes of optimal or “stent-like”balloon angioplasty in acutemyocardial infarction: the CADILLAC trial

David A. Cox, Gregg W. Stone, Cindy L. Grines et al. · Journal of the American College of Cardiology · 2003 · 24 citations

Medicine, Cardiology, Internal Medicine +15